HKT-500 in Adult Patients With Shoulder Pain
Public ClinicalTrials.gov record NCT00680472. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Protocol HKT-500-US08: A Randomized, Multicenter, Double-blind, Placebo-controlled, Two-week Study to Assess the Efficacy and Safety of HKT-500 in Subjects With Acute Shoulder Pain
Study identification
- NCT ID
- NCT00680472
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Industry
- Enrollment
- 368 participants
Conditions and interventions
Conditions
Interventions
- HKT-500 Ketoprofen Topical Patch Drug
- Placebo Patch Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2008
- Primary completion
- Sep 30, 2008
- Completion
- Sep 30, 2008
- Last update posted
- Jun 3, 2015
2008
United States locations
- U.S. sites
- 35
- U.S. states
- 19
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hisamitsu Investigator Site | Birmingham | Alabama | 35209 | — |
| Hisamitsu Investigator Site | Tempe | Arizona | 85283 | — |
| Hisamitsu Investigator Site | Fullerton | California | 92835 | — |
| Hisamitsu Investigator Site | Denver | Colorado | 80204 | — |
| Hisamitsu Investigator Site | Washington D.C. | District of Columbia | 20003 | — |
| Hisamitsu Investigator Site | Bradenton | Florida | 34209 | — |
| Hisamitsu Investigator Site | Chiefland | Florida | 32626 | — |
| Hisamitsu Investigator Site | DeLand | Florida | 32720 | — |
| Hisamitsu Investigator Site | Delray Beach | Florida | 33484 | — |
| Hisamitsu Investigator Site | Dunedin | Florida | 34698 | — |
| Hisamitsu Investigator Site | Longwood | Florida | 32779 | — |
| Hisamitsu Investigator Site | Oldsmar | Florida | 34677 | — |
| Hisamitsu Pharmaceutical Co., Inc. | Orange City | Florida | 32763 | — |
| Hisamitsu Investigator Site | Plantation | Florida | 33324 | — |
| Hisamitsu Investigator Site | Tampa | Florida | 33603 | — |
| Hisamitsu Investigator Site | Tampa | Florida | 33609 | — |
| Hisamitsu Investigator Site | Blue Ridge | Georgia | 30513 | — |
| Hisamitsu Investigator Site | Boise | Idaho | 83702 | — |
| Hisamitsu Investigator Site | Wichita | Kansas | 67205 | — |
| Hisamitsu Investigator Site | Paducah | Kentucky | 42003 | — |
| Hisamitsu Investigator Site | Bowie | Maryland | 20716 | — |
| Hisamitsu Investigator Site | Kalamazoo | Michigan | 49009 | — |
| Hisamitsu Investigator Site | Bridgewater | New Jersey | 08807 | — |
| Hisamitsu Investigator Site | Cary | North Carolina | 27513 | — |
| HIsamitsu Pharmaceutical Co., Inc. | Durham | North Carolina | 27704 | — |
| Hisamitsu Investigator Site | Raleigh | North Carolina | 27615 | — |
| Hisamitsu Investigator Site | Fargo | North Dakota | 58104 | — |
| Hisamitsu Investigator Site | Fargo | North Dakota | 58108 | — |
| HIsamitsu Pharmaceutical Co., Inc. | Perrysburg | Ohio | 43551 | — |
| Hisamitsu Investigator Site | Toledo | Ohio | 43623 | — |
| Hisamitsu Investigator Site | Zanesville | Ohio | 43701 | — |
| Hisamitsu Investigator Site | New Tazewell | Tennessee | 37825 | — |
| Hisamitsu Investigator Site | Bryan | Texas | 77802 | — |
| Hisamitsu Investigator Site | San Antonio | Texas | 78217 | — |
| Hisamitsu Investigator Site | Newport News | Virginia | 23606 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00680472, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 3, 2015 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00680472 live on ClinicalTrials.gov.